MedTrace Logo

Freedom® Cervical Disc Use In The Treatment of Cervical Degenerative Disc Disease

NCT01763619 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-07-29

No results posted yet for this study

Summary

This study will collect clinical and radiographic data on the Freedom Cervical Disc to monitor the device's safety and performance as part of a post-market evaluation.

Conditions

  • Symptomatic Cervical Degenerative Disc Disease (DDD) From C3-C7

Interventions

DEVICE

Freedom Cervical Disc

Sponsors & Collaborators

  • AxioMed Spine Corporation

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • Germany
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01763619 on ClinicalTrials.gov